You are here

Study Evaluating Management of Patients With Moderate and Severe Psoriasis

Last updated on November 9, 2019

FOR MORE INFORMATION
Study Location
Madrid, , 28031 Spain
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Psoriasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

·Over 18 years of age.·Diagnosed with moderate or severe psoriasis.·Initiated treatment
with topical and/or systemic treatment between two and five years before enrollment in the
study. ·Has a clinical record at the dermatologist office.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

·Currently participating in a clinical study. ·Clinical record lacks minimum data required
for observational analysis.

NCT00894777
Pfizer
Completed
Study Evaluating Management of Patients With Moderate and Severe Psoriasis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Psoriasis Vulgaris, Psoriasis Arthropathica, Pustular Psoriasis, Erythrodermic Psoriasis
NCT03885089
All Genders
0+
Years
Tokyo,
Descriptive Information
Brief TitleStudy Evaluating Management of Patients With Moderate and Severe Psoriasis
Official TitleManagement of Patients With Moderate and Severe Psoriasis Under Treatment With Topical and/or Systemic Drugs
Brief SummaryThis is an observational, naturalistic, multicenter, retrospective study to describe the therapeutic management of patients with moderate and severe psoriasis under treatment with topical and/or systemic drugs in usual clinical practice in Spain.
Detailed DescriptionNot Provided
Study TypeObservational
Study DesignObservational Model: Case-Only
Time Perspective: Retrospective
Target Follow-Up DurationNot Provided
BiospecimenNot Provided
Sampling MethodProbability Sample
Study PopulationPatients with moderate and severe psoriasis under treatment with topical and/or systemic drugs in usual clinical practice
ConditionPsoriasis
InterventionOther: Clinical record review
Study Groups/Cohorts1
Patients with moderate and severe psoriasis under treatment with topical and/or systemic drugs
Intervention: Other: Clinical record review
Publications *Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment StatusCompleted
Actual Enrollment
 (submitted: October 27, 2010)
469
Original Estimated Enrollment
 (submitted: May 6, 2009)
500
Actual Study Completion DateNovember 2009
Actual Primary Completion DateNovember 2009   (Final data collection date for primary outcome measure)
Eligibility Criteria

Main Inclusion Criteria:

·Over 18 years of age.·Diagnosed with moderate or severe psoriasis.·Initiated treatment with topical and/or systemic treatment between two and five years before enrollment in the study. ·Has a clinical record at the dermatologist office.

Main Exclusion Criteria:

·Currently participating in a clinical study. ·Clinical record lacks minimum data required for observational analysis.

Sex/Gender
Sexes Eligible for Study:All
Ages18 Years and older   (Adult, Older Adult)
Accepts Healthy VolunteersNo
ContactsContact information is only displayed when the study is recruiting subjects
Listed Location CountriesSpain
Removed Location Countries  
 
Administrative Information
NCT NumberNCT00894777
Other Study ID Numbers0881A6-4577
Has Data Monitoring CommitteeNo
U.S. FDA-regulated ProductNot Provided
IPD Sharing StatementNot Provided
Responsible PartyDirector, Clinical Trial Disclosure Group, Wyeth
Study SponsorWyeth is now a wholly owned subsidiary of Pfizer
CollaboratorsNot Provided
Investigators
Study Director:Pfizer CT.gov Call CenterWyeth is now a wholly owned subsidiary of Pfizer
PRS AccountWyeth is now a wholly owned subsidiary of Pfizer
Verification DateNovember 2010

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now